Cancer Research and Biotechnology AG

Menu

HEALING THE

DISEASE THAT

CAUSES CANCER

DISCOVER MORE

 

Cancer Research and Biotechnology AG is a Swiss preclinical oncology company focusing on metabolic diseases and mitochondrial healing for cancer treatments.

We are healing the disease that causes cancer. Our lead product corrects the root metabolic dysfunctions by restoring proper mitochondrial and cellular functions

 

 

 

For decades, cancer therapy has meant a painful trade-off: damage the tumour, but also the patient. 

We are changing that equation. 

By targeting cancer’s metabolic engine and restoring healthy mitochondrial function, we can stop cancer progression while protecting normal tissue.

 

 

TARGETING DEADLY CANCERS

The first target is Metastatic Melanoma, a very aggressive form of skin cancer.

Our drug has shown efficacy and safety on human cancer cells, and it will soon be studied in clinical trials.

LEARN MORE
figurenpop.de

The balance wheel, oscillating with metronomic precision at 28,800 beats per hour or more, acts as the guardian of time. This is the escapement, a miraculous piece of physics that allows energy to escape in measured, tiny increments, governing the relentless march of seconds, minutes, and hours.

Each screw head is polished to a mirror sheen, and every surface, even those never seen by the naked eye, is finished by the hand of a master craftsman. This obsessive dedication to beauty in the hidden places is not for vanity; it is a promise. A promise of quality, of integrity, and of a standard that refuses to compromise.